compounded semaglutide drops Sublingual for Weight Loss Instructions for Oral Compounded GLP-1

With medications Blood thinners (warfarin, aspirin) - May increase bruising at injection sites

Low body temperature

SURMOUNT-3 and SURMOUNT-4 Trials (2023) In a 2023 NEJM publication , researchers reported that Retatrutide: Produced an average of 24.2% total body weight loss at 48 weeks in individuals without diabetes Patients on the highest dose lost over 58 pounds on average Outperformed all currently available GLP-1 and GIP analogs Additional findings included: Significant reduction in liver fat (up to 85%) Improved insulin sensitivity and HOMA-IR scores Reduced blood pressure, triglycerides, and inflammation markers These results are unmatched in obesity pharmacotherapy history and suggest that Retatrutide could soon set a new gold standard for metabolic treatment

like Spain [22], and the US [23]

Providers should offer continued coaching and encouragement for healthy lifestyle habits including 150 minutes per week of moderate physical activity and a balanced diet

Rather than dismissing microdosing as a fad, we should be studying it rigorously